 Nes Ziona, Israel, Jan. 11, 2021 GLOBE NEWSWIRE -- Enlivex Therapeutics Ltd. Nasdaq: ENLV, the Company, a clinical-stage macrophage reprogramming immunotherapy company, today announced that Company management will present at the H.C. Wainwright BioConnect 2021 Virtual Conference. The presentation will be available on-demand through the conference website from January 11, 2021 starting at 6:00 a.m. ET. 